NYSE: CLB · Oil & Gas Equipment & Services
Core Laboratories (CLB) fair value: undervalued or overvalued?
As of 29 Sep 2026, Faircurve's model values Core Laboratories (CLB) at $8.52 a share. The stock last closed at $9.92, which puts the model's fair value 14.1% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 2 Oct 2026. Core Laboratories N.V.
Faircurve Insights · 29 Sep 2026
Core Laboratories N.V. is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction.
Faircurve's model on 29 Sep 2026 found a fair value of $8.52 a share, the midpoint of 2,000 simulations. The previous run, on 26 Sep 2026, gave $8.87, so the fair value moved -3.9%. The model’s calibrated range over 63 trading days is $7.15 to $10.39, built from the fair value and calibrated weekly against realised prices, and held the price 60% of the time at this horizon. The evidence grade for this valuation is High.
The overall quality score against comparable companies is 65 out of 100. Its profitability score is 100, with ROIC at 7.7% against a peer median of 6.4%. The model compares it with Bristow Group Inc., RPC, Inc., Innovex International, Inc., Liberty Energy Inc., Tidewater Inc., Cactus, Inc., and Oceaneering International, Inc. The median move around the last 8 earnings reports, ignoring direction, was 7.1%.
Written from the figures on this page for the 29 Sep 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give CLB?
The calibrated range for CLB over 63 trading days is $7.15 to $10.39. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $6.58 to $10.70. In 27% of the simulations the fair value came out above the price the model ran on.
How does CLB score on business quality?
Core Laboratories's overall quality score is 65 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 100 | 7.7%ROIC | 6.4% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 31 | 0.44xFCF / net income | -0.75x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analyst estimate revisions. | 25 | 0.5%Revenue growth, trailing | 4.8% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 92 | 3.1%Net buybacks / market value | 0.0% |
| Balance sheetNet debt to EBITDA and interest coverage. | 49 | 2.27xNet debt / EBITDA | 2.30x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 100 | 0.6 ptsEBITDA margin downside volatility, 5y | 9.9 pts |
How does CLB compare with similar companies?
The companies in oil & gas equipment & services closest to Core Laboratories in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| VTOL Bristow Group Inc. | $40.26 | $49.00 | +21.7% | Undervalued |
| RES RPC, Inc. | $5.86 | $7.47 | +27.5% | Undervalued |
| AESI Atlas Energy Solutions Inc. | $12.04 | $8.08 | -32.9% | Low evidence grade |
| INVX Innovex International, Inc. | $27.31 | $24.78 | -9.3% | Fairly valued |
| LBRT Liberty Energy Inc. | $19.31 | $18.48 | -4.3% | Fairly valued |
| TDW Tidewater Inc. | $82.42 | $83.54 | +1.4% | Fairly valued |
| WHD Cactus, Inc. | $63.44 | $63.89 | +0.7% | Fairly valued |
| OII Oceaneering International, Inc. | $44.32 | $41.77 | -5.8% | Fairly valued |
All oil & gas equipment & services stocks ranked by gap to fair value
When does CLB report earnings, and how has the stock reacted?
Core Laboratories's next earnings report is scheduled for 28 Oct 2026. Companies can move their dates.
How CLB moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 7.1%.
| Report date | Two session move |
|---|---|
| 29 Jul 2026 | -3.2% |
| 29 Apr 2026 | -12.6% |
| 4 Feb 2026 | -4.4% |
| 22 Oct 2025 | +36.6% |
| 23 Jul 2025 | +13.5% |
| 23 Apr 2025 | -2.5% |
| 29 Jan 2025 | -4.2% |
| 23 Oct 2024 | +9.8% |
Core Laboratories at a glance
Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction.
- Market value
- $479M
- Sector
- Energy
- Industry
- Oil & Gas Equipment & Services
- Revenue expected, next twelve months
- $521M
- Consensus revenue growth, next fiscal year
- -3.0%
- Analysts with estimates
- 2
- Beta to the US market
- 1.17
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model prices Core Laboratories on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 26 Sep 2026 the model's fair value for CLB was $8.87. As of 29 Sep 2026 it is $8.52, a change of -3.9%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Core Laboratories's valuation
Is Core Laboratories stock undervalued or overvalued?
On Faircurve's model, CLB reads as Fairly valued as of 29 Sep 2026. The model's fair value is $8.52 a share against a last close of $9.92, a gap of -14.1%.
What is CLB's fair value?
$8.52 a share as of 29 Sep 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $6.58 to $10.70.
What price range does the model give CLB?
$7.15 to $10.39 over 63 trading days. Ranges built this way held the price 60% of the time across 4,327 past valuations, refreshed 26 Sep 2026.
When does Core Laboratories report earnings next?
The next report is scheduled for 28 Oct 2026. Companies can move their dates.
How much has CLB moved on past earnings reports?
Across its last 8 reports the median two session move was 7.1%, ignoring direction. The largest was +36.6% around the report of 22 Oct 2025.
How confident is the model in this valuation?
The model's evidence grade for CLB is high. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.